Hanmi Pharm. Co., Ltd. (KRX: 128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
238,000
+4,000 (1.71%)
Feb 3, 2025, 9:00 AM KST

Hanmi Pharm. Revenue

Hanmi Pharm. had revenue of 362.08B KRW in the quarter ending September 30, 2024, a decrease of -0.70%. This brings the company's revenue in the last twelve months to 1.57T, up 10.32% year-over-year. In the year 2023, Hanmi Pharm. had annual revenue of 1.49T with 11.97% growth.

Revenue (ttm)
1,566.25B
Revenue Growth
+10.32%
P/S Ratio
2.04
Revenue / Employee
672.21M
Employees
2,330
Market Cap
3,189.07B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231,490.89B159.34B11.97%
Dec 31, 20221,331.55B128.36B10.67%
Dec 31, 20211,203.19B127.33B11.84%
Dec 31, 20201,075.85B-37.80B-3.39%
Dec 31, 20191,113.65B97.69B9.62%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics Co.,Ltd. 4,364.39B
Celltrion 2,876.25B
Yuhan 2,008.84B
SK Biopharmaceuticals 511.33B
SK bioscience Co.,Ltd. 201.30B
Hanall Biopharma 134.24B
Hanmi Science 1,283.65B
Daewoong Pharmaceutical 1,416.63B
Revenue Rankings